Clinical trial
Studies With 1,25-Dihydroxycholecalciferol
NCT00001151 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH · Terminated
Key facts
| NCT number | NCT00001151 |
|---|---|
| Title | Studies With 1,25-Dihydroxycholecalciferol |
| Official title | Studies With 1,25-Dihydroxycholecalciferol |
| Lead sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hypocalcemia, Rickets |
| Intervention type | Drug |
| Interventions | 1, 25-Dihydroxycholecalciferol |
| Enrollment | 6 |
| Start date | Mar 1, 1976 |
| Primary completion | Oct 1, 2009 |
| Completion | Oct 1, 2009 |
| First posted | Nov 4, 1999 |
| Last update posted | Nov 25, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: